2026年3月最新《新锐期刊分区表》数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Journal for ImmunoTherapy of Cancer J IMMUNOTHER CANCER （此期刊被最新的JCR期刊SCIE收录） LetPub评分 8.6
65人评分
我要评分
声誉 9.3 影响力 8.1 速度 7.0 | |||||||||||||||||||||||||||||||||||||
| 期刊ISSN | 2051-1426 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 10.6 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：10.95 | |||||||||||||||||||||||||||||||||||||
| 2024-2025自引率 | 2.8%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||||||||
| 五年影响因子 | 11.5 | |||||||||||||||||||||||||||||||||||||
| JCI期刊引文指标 | 2.15 | |||||||||||||||||||||||||||||||||||||
| h-index | 36 | |||||||||||||||||||||||||||||||||||||
| CiteScore （ 2025年最新版） |
| |||||||||||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||||||||||
| 期刊官方网站 | https://jitc.bmj.com/ | |||||||||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||||||||
| 期刊投稿网址 | https://mc.manuscriptcentral.com/jitc | |||||||||||||||||||||||||||||||||||||
| 作者指南网址 | https://jitc.bmj.com/pages/authors | |||||||||||||||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Fecal microbiota transplantation combined with anti-PD-1 therapy in refractory microsatellite-stable gastric cancer: a phase I feasibility and safety study Author: Zhang, Yifan; Xu, Xiaomin; Wang, Shulin; Yin, Xiaochen; Zhang, Bohan; Zhu, Zhengnong; Ji, Rujie; Zhu, Jing; He, Hermione; Cheng, Siyuan; Han, Zihan; Xie, Tong; Zhang, Xiaotian; Wang, Yakun; Shen, Si; Kou, Yan; Bao, Siyu; Liu, Yingyu; Cao, Baoran; Bonny, Christophe; Guo, Xiaohuan; Segal, Eran; Tan, Yan; Shen, Lin; Peng, Zhi Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1136/jitc-2025-013823 Single-cell-based identification of drug synergy with immunotherapy via tumor microenvironment remodeling Author: Wang, Ziruoyu; Hu, Junchi; Liu, Kailu; Xu, Jie; Li, Jiao; Liu, Yihang; Ma, Qinfeng; Dong, Yu; Zhu, Yunmei; Zhang, Kai; Wang, Dexin; Wang, Xiaobo; Wang, Shuai; Pan, Jianbo; Jiang, Shuai; Wu, Jiaxue; Jiang, Wei; Zhang, Ling; Dang, Yongjun Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1136/jitc-2025-014132 Intratumoral PD-1-directed IL-2 expression via oncolytic vaccinia virus elicits superior antitumor effects with enhanced safety Author: Chen, Lingjuan; Ye, Junjie; Patel, Sefali; Ming, Pingpo; Li, Chunyan; Waltermire, Julia; Zhao, Jinshun; Ren, Jinghua; Bartlett, David L.; Liu, Zuqiang Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1136/jitc-2024-011340 Role of solute carrier family 7 member 7 in cancer: opportunities for tumor microenvironment research Author: Zhang, Zhentao; Lv, Jiani; Li, Jiang Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1136/jitc-2025-014658 | |||||||||||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Journal for ImmunoTherapy of Cancer的语言要求，还能让Journal for ImmunoTherapy of Cancer编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Journal for ImmunoTherapy of Cancer编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢（2篇） 。
提交文稿 | |||||||||||||||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ USD3180; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：tumour immunology、cancer immunotherapy、immunotherapy biomarkers 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||||||||||||||
| 通讯方式 | BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND, WC1H 9JR | |||||||||||||||||||||||||||||||||||||
| 出版商 | BMJ PUBLISHING GROUP | |||||||||||||||||||||||||||||||||||||
| 涉及的研究方向 | Biochemistry, Genetics and Molecular Biology-Molecular Medicine | |||||||||||||||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||||||||||||||||||
| 出版年份 | 2013 | |||||||||||||||||||||||||||||||||||||
| 年文章数 | 422点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||||||||
| Gold OA文章占比 | 99.56% | |||||||||||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 95.02% | |||||||||||||||||||||||||||||||||||||
| WOS期刊JCR分区 （ 2024-2025年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2051-1426%5BISSN%5D | |||||||||||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 18 Weeks | |||||||||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费：需要（ USD3180; ） 文章处理费豁免：查看说明 其他费用：没有 LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！ | |||||||||||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Journal for ImmunoTherapy of Cancer顺利发表。
快看看作者怎么说吧：服务好评 论文致谢（2篇） 。 提交文稿 | |||||||||||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Fecal microbiota transplantation combined with anti-PD-1 therapy in refractory microsatellite-stable gastric cancer: a phase I feasibility and safety study Author: Zhang, Yifan; Xu, Xiaomin; Wang, Shulin; Yin, Xiaochen; Zhang, Bohan; Zhu, Zhengnong; Ji, Rujie; Zhu, Jing; He, Hermione; Cheng, Siyuan; Han, Zihan; Xie, Tong; Zhang, Xiaotian; Wang, Yakun; Shen, Si; Kou, Yan; Bao, Siyu; Liu, Yingyu; Cao, Baoran; Bonny, Christophe; Guo, Xiaohuan; Segal, Eran; Tan, Yan; Shen, Lin; Peng, Zhi Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1136/jitc-2025-013823 PubMed DOI |
| 2. | Single-cell-based identification of drug synergy with immunotherapy via tumor microenvironment remodeling Author: Wang, Ziruoyu; Hu, Junchi; Liu, Kailu; Xu, Jie; Li, Jiao; Liu, Yihang; Ma, Qinfeng; Dong, Yu; Zhu, Yunmei; Zhang, Kai; Wang, Dexin; Wang, Xiaobo; Wang, Shuai; Pan, Jianbo; Jiang, Shuai; Wu, Jiaxue; Jiang, Wei; Zhang, Ling; Dang, Yongjun Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1136/jitc-2025-014132 PubMed DOI |
| 3. | Intratumoral PD-1-directed IL-2 expression via oncolytic vaccinia virus elicits superior antitumor effects with enhanced safety Author: Chen, Lingjuan; Ye, Junjie; Patel, Sefali; Ming, Pingpo; Li, Chunyan; Waltermire, Julia; Zhao, Jinshun; Ren, Jinghua; Bartlett, David L.; Liu, Zuqiang Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1136/jitc-2024-011340 PubMed DOI |
| 4. | Role of solute carrier family 7 member 7 in cancer: opportunities for tumor microenvironment research Author: Zhang, Zhentao; Lv, Jiani; Li, Jiang Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1136/jitc-2025-014658 PubMed DOI |
| 5. | Dual regulation of CXCR6+CD8+ T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression Author: Xingming, Zhang; Wang, Jianhua; Abudurexiti, Mierxiati; Du, Leilei; Zhang, Wei; Ni, Xudong; Xu, Midie; Zhang, Xiaoyan; Zhang, Min; Yao, Zhu; Bian, Xiaojie; Jin, Shengming; Wang, Wenfeng Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1136/jitc-2025-014276 PubMed DOI |
| 6. | AGPAT3 reshapes tumor cell vulnerability to IFNγ-mediated ferroptosis and enhances immunotherapy efficacy through lipid remodeling Author: Liu, Chuan; Hu, Chuan; Cheng, Jinlin; Xin, Duanfeng; Jin, Sujie; Tian, Weihong; Li, Shan; Jin, Yuzhi; Liu, Yu; Hao, Shuqiang; Wu, Wei; Ren, Hui; Dai, Xiaomeng; Liu, Lulu; Ruan, Jian; Fang, Weijia; Bao, Xuanwen; Xin, Shan; Zhao, Peng Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1136/jitc-2025-013305 PubMed DOI |
| 7. | Hyaluronic acid-CD44 signaling defines therapeutic resistance and immunosuppressive microenvironment in peritoneal metastasis of gastric cancer Author: Zhao, Junjie; Ji, Chengbo; Sun, Jie; Tian, Chenyu; Cai, Tianyi; Wang, Zhaoming; Sun, Zhaodong; Li, Bosen; Ma, Guoxing; Liu, Dan; Yamamoto, Masami; Tsukamoto, Tetsuya; Nomura, Sachiyo; Sun, Liming; Sun, Yihong; Huang, Liyu; Ruan, Yuanyuan; Li, Haojie; Wang, Xuefei Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1136/jitc-2025-014179 PubMed DOI |
| 8. | Fluorination augments tumor engagement and antitumor immunity of a D-peptide-based radiotheranostic agent for combinatorial immune checkpoint blockade therapy Author: Zhang, Siqi; Liu, Can; Lu, Qingshuang; Liu, Wenhao; Wu, Jiang; Liu, Jianjing; Tong, Lina; Zhao, Kuo; Hu, Qichen; Chen, Xueyao; Li, Linger; Song, Xuekai; Wang, Feng; Dai, Dong; Wang, Rui; Hu, Kuan Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1136/jitc-2025-013732 PubMed DOI |
| 9. | First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers Author: Yoo, Changhoon; Fabregat-Franco, Carles; Lin, Chia-Chi; Qvortrup, Camilla; Oh, Do-Youn; Yau, Thomas; Kim, Hyung-Don; Castet, Florian; Ponz Sarvise, Mariano; Hsu, Chiun; Rohrberg, Kristoffer Staal; Lichtenegger, Felix Sebastian; Franjkovic, Izolda; Kratochwil, Nicole A.; Bessa, Juliana; Rossmann, Eva; Schwalie, Petra C.; Rieder, Natascha; Poschinger, Thomas; Sie, Christina Godfried; Dettling, Steffen; Schlenker, Ramona; Jiang, Tianyi; Dai, Congqi; Yun, Hongying; Hall, Elia; Yeo Te-Ying, Audrey; Hoves, Sabine; Cannarile, Michael A.; Schiff, Christina; Sangro, Bruno Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1136/jitc-2025-012783 PubMed DOI |
| 10. | Targeting endosomal trafficking-mediated antigen escape to resensitize myeloma to CAR-T therapy Author: Wang, Zhuning; Wang, Guanli; Liu, Yujie; Zhao, Yufei; Guo, Shushan; Yang, Yicun; Zhang, Qikai; Hu, Chaolu; Chang, Shuaikang; Wu, Xiaosong; An, Dong; Hu, Huifang; Cai, Haiyan; Zhang, Li; Shi, Jumei Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1136/jitc-2025-014040 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共380条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
